Here's Why Amarin Tumbled 67.7% in the First Half of 2020

Here's Why Amarin Tumbled 67.7% in the First Half of 2020

The pharma stock collapsed on the threat of generic competition for a drug that launched in December 2019, but the move may have been a bit of an overreaction.